Patient Name : Ms.

CHITRA JHA Collected : 11/Jan/2025 10:30AM

Age/Gender : 26 Y 0 M 5 D /F Received : 12/Jan/2025 02:59PM
UHID/MR No : APJ1.0002966124 Reported : 12/Jan/2025 04:15PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Unit Bio. Ref. Interval Method

DEHYDROEPIANDROSTERONE 240.8 µg/dL 25.9-460.2 CLIA
SULPHATE - (DHEAS) , SERUM

Comment:
DHEAS is an Indicator of adrenal cortical function, especially for differential diagnosis of virilization, and investigations of hirsutism
and alopecia in women. It is also of value in the assessment of adrenarche and delayed puberty.
Levels are increased in CAH, adrenal carcinoma, Cushing syndrome caused by adrenal hyperplasia, and PCOS. Extremely high
levels (>700 or 800 μg/dL) in women are suggestive of a hormone-secreting adrenal tumor. By contrast, levels are typically
normal in the presence of ovarian tumors.
Drugs that may increase DHEA-S levels include metformin, troglitazone, prolactin, danazol, calcium channel blockers (e.g.,
diltiazem, amlodipine), and nicotine

Page 1 of 7

SIN No:IM08973539
This test has been performed at Apollo Health & Lifestyle Ltd, Global Reference Laboratory,Hyderabad
Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 10:30AM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 05:57PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 07:21PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Unit Bio. Ref. Interval Method

FSH, LH, PROLACTIN , SERUM
LH:LUTEINIZING HORMONE 3.40 mlU/mL CLIA
FOLLICLE STIMULATING HORMONE 4.08 mlU/mL CLIA
(FSH)
PROLACTIN 73.16 ng/mL 3.3 - 26.7 CLIA

Result is rechecked. Kindly correlate clinically.

Comment:
LH:-
REFERENCE GROUP REFERENCE RANGE IN mIU/mL
FEMALES
* FOLLICULAR PHASE 2.1 – 11.0
MID CYCLE PEAK 19.2 – 103
LUTEAL PHASE 1.2 – 12.8
PREGNANCY < 1.5
POST MENOPAUSAL 10.8 – 58.6
MALES 1.2 – 8.6

Abnormal LH levels are interpreted with increased or decreased levels of other fertility hormones such as FSH, estrogens,
progesterone, and testosterone.
Increased LH levels are associated primary ovarian hypogonadism and gonadotropin secreting pituitary tumors. Decreased LH
levels are associated with Hypothalamic GnRH deficiency, Pituitary LH deficiency, Ectopic steroid hormone production, GnRH
analog treatment.

FSH:-
REFERENCE GROUP REFERENCE RANGE IN mIU/mL
FEMALES
* FOLLICULAR PHASE 2.5 – 10.2
* MID CYCLE PEAK 3.4 – 33.4
* LUTEAL PHASE 1.5 – 9.1
Page 2 of 7

SIN No:IM08972182
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 10:30AM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 05:57PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 07:21PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY
* PREGNANCY < 0.3
* POST MENOPAUSAL 23-116
MALES 1.4- 18.1

Abnormal FSH levels are interpreted with increased or decreased levels of other fertility hormones such as LH, estrogens,
progesterone, and testosterone.

Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in
males.Decreased FSH levels are associated with primary ovarian hyperfunction in females and primary hypergonadism in males.
Normal or decreased FSH levels are associated with polycystic ovary disease in females.

PROLACTIN:-
REFERENCE GROUP REFERENCE RANGE IN ng/mL
ADULT FEMALES
* PRE-MENOPAUSAL 3.3 – 26.7
* PREGNANCY 9.7 – 208.5
* POST MENOPAUSAL 2.7 – 19.6
MALES 2.6 – 13.1
Normal prolactin secretion varies with time, which results in serum prolactin levels two to three times higher at night than during the
day.
Serum prolactin levels during the menstrual cycle are variable and commonly exhibit slight elevations during the mid-cycle. Prolactin
levels in normal individuals tend to rise in response to physiologic stimuli including sleep, exercise, nipple stimulation, sexual
intercourse, hypoglycemia, pregnancy, and surgical stress.
Prolactin values that exceed the reference values may be due to macroprolactin (prolactin bound to immunoglobulin).
Macroprolactin should be evaluated if signs and symptoms of hyperprolactinemia are absent or pituitary imaging studies are not
informative

Page 3 of 7

SIN No:IM08972182
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 10:30AM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 05:57PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 06:54PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Unit Bio. Ref. Interval Method

ULTRASENSITIVE TSH
ULTRA SENSITIVE TSH 7.84 µIU/mL 0.35-4.94 CLIA

Comment:
TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH is a labile hormone & is secreted in a pulsatile manner
throughout the day and is subject to several non-thyroidal pituitary influences.Significant variations in TSH can occur with
circadian rhythm, hormonal status, stress, sleep deprivation, caloric intake, medication & circulating antibodies.
It is important to confirm any TSH abnormality in a fresh specimen drawn after ~ 3 weeks before assigning a diagnosis, as
the cause of an isolated TSH abnormality.
Bio Ref Range for TSH in uIU/ml (As per
For pregnant females
American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0

Page 4 of 7

SIN No:IM08972182
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 04:32PM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 07:29PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 08:31PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Unit Bio. Ref. Interval Method

INSULIN (PP) , SERUM 94.93 uIU/mL 16-166* CLIA

Page 5 of 7

SIN No:IM08972183
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 10:30AM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 05:57PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 06:54PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Unit Bio. Ref. Interval Method

SEX HORMONE BINDING GLOBULIN 84.80 nmol/L 18.2-135.5 CLIA
(SHBG) , SERUM

Comment:
The measurement of SHBG can be an important indicator of a chronic or excessive androgenic activity where clinicalsymptoms
would seem to indicate androgen in excess, but androgen levels are normal. Elevated SHBG levels can be seen in persons with
androgen insensitivities, hyperthyroidism, cirrhosis of the liver and is found in patients on oral contraceptives or antiepileptic drugs.
Decreased concentrations of SHBG are often seen in men with hypothyroidism and androgen replacement therapy; where women
with hirsutism, virilism, polycystic ovarian syndrome (PCOS), elevated androgen levels, obesity and acromegaly will also see a
decrease in SHBG levels.
SHBG production is regulated by the androgen/estrogen balance, thyroid hormones, insulin, and dietary factors. Pregnant women
have markedly higher SHBG serum concentrations due to their increased estrogen production.

Page 6 of 7

SIN No:IM08972182
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 10:30AM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 05:57PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 07:22PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

DEPARTMENT OF IMMUNOLOGY

Test Name Result Unit Bio. Ref. Interval Method

TESTOSTERONE- FREE , SERUM 0.01 nmol/L 0.006-0.055 Calculated

An indirect method calculation using equations has been used to derive the free testosterone concentration (Ftc) based on serum
Albumin, serum SHBG & serum testosterone values. Suggested clinical correlation.

Comment:
Usually, bioavailable and free testosterone levels parallel the total testosterone levels. However, a number of conditions and
medications are known to increase or decrease the sex hormone-binding globulin (SHBG) concentration, which may cause total
testosterone concentration to change without necessarily influencing the bioavailable or free testosterone concentration, or vice
versa.

Treatment with corticosteroids and sex steroids (particularly oral conjugated estrogen) can result in changes in SHBG levels and
availability of sex-steroid binding sites on SHBG. In polycystic ovarian syndrome and related conditions, there is often significant
insulin resistance, which is associated with low SHBG levels. Consequently, bioavailable or free testosterone levels may be more
significantly elevated.

The correlation coefficient between bioavailable and free testosterone (by equilibrium dialysis) is 0.9606

*** End Of Report ***

Page 7 of 7

SIN No:IM08972182
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory
 Patient Name : Ms.CHITRA JHA Collected : 11/Jan/2025 10:30AM
Age/Gender : 26 Y 0 M 5 D /F Received : 11/Jan/2025 05:57PM
UHID/MR No : APJ1.0002966124 Reported : 11/Jan/2025 07:22PM
Visit ID : DNWTOPV21751 Status : Final Report
Ref Doctor : Dr. Mitika Sobti Client Name : APOLLO 24X7
IP/OP NO : Center location : New Town S.O,Kolkata

TERMS AND CONDITIONS GOVERNING THIS REPORT

1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of technologies.Laboratories not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.

SIN No:IM08972182
This test has been performed at Apollo Health & Lifestyle Ltd, RRL Kolkata Laboratory